These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2671702)

  • 1. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis.
    Reddy JK; Rao MS
    Mutat Res; 1989 Sep; 214(1):63-8. PubMed ID: 2671702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
    Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK
    Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proliferation of peroxisomes and the hepatocarcinogenic process].
    Palut D
    Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.
    Tamura H; Iida T; Watanabe T; Suga T
    Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of peroxisome proliferator-induced hepatocarcinogenesis.
    Rao MS; Reddy JK
    Environ Health Perspect; 1991 Jun; 93():205-9. PubMed ID: 1685443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
    Tomaszewski KE; Agarwal DK; Melnick RL
    Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
    Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA
    Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator.
    Kasai H; Okada Y; Nishimura S; Rao MS; Reddy JK
    Cancer Res; 1989 May; 49(10):2603-5. PubMed ID: 2713844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.
    Yeldandi AV; Rao MS; Reddy JK
    Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenobiotic-induced peroxisome proliferation: role of tissue specificity and species differences in response in the evaluation of the implications for human health.
    Reddy JK; Rao MS
    Arch Toxicol Suppl; 1987; 10():43-53. PubMed ID: 3555419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats.
    Hayashi F; Tamura H; Yamada J; Kasai H; Suga T
    Carcinogenesis; 1994 Oct; 15(10):2215-9. PubMed ID: 7955056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
    Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
    Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes.
    Fahl WE; Lalwani ND; Watanabe T; Goel SK; Reddy JK
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7827-30. PubMed ID: 6096860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
    Reddy JK; Reddy MK; Usman MI; Lalwani ND; Rao MS
    Environ Health Perspect; 1986 Mar; 65():317-27. PubMed ID: 3709457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid.
    Marsman DS; Goldsworthy TL; Popp JA
    Carcinogenesis; 1992 Jun; 13(6):1011-7. PubMed ID: 1600604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of induction of hepatic DNA damage on long-term administration of peroxisome proliferators in male F-344 rats.
    Tamura H; Iida T; Watanabe T; Suga T
    Toxicology; 1991; 69(1):55-62. PubMed ID: 1926155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferation and lipid peroxidation in rat liver.
    Goel SK; Lalwani ND; Reddy JK
    Cancer Res; 1986 Mar; 46(3):1324-30. PubMed ID: 3943099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocarcinogenesis of peroxisome proliferators.
    Rao MS; Reddy JK
    Ann N Y Acad Sci; 1996 Dec; 804():573-87. PubMed ID: 8993574
    [No Abstract]   [Full Text] [Related]  

  • 19. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis.
    Lake BG
    Toxicol Lett; 1995 Dec; 82-83():673-81. PubMed ID: 8597126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic peroxisome proliferation in rodents and its significance for humans.
    Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ
    Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.